Popular Articles From: New Air Products Microsite Illustrates Novel Ways Liquid Nitrogen Can Improve Food Processing Operations to Multiple Data Presentations at the 2014 American Society of Hematology (ASH) Annual Meeting Showcase Incyte's Leadership in the Field of Myeloproliferative Neoplasms (MPNs)


MENLO PARK, Calif.
Sign-up for Nevro Corp. Announces Pricing of Initial Public Offering investment picks
NeuroMetrix, Inc. (Nasdaq: NURO) will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) January 6-9 in Las Vegas.
Sign-up for NeuroMetrix to Showcase Quell™ Wearable Pain Relief Technology at the 2015 International Consumer Electronics Show investment picks
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will join an exclusive number of companies to participate in CES Unveiled, the official press event of the International Consumer Electronics Show in Las Vegas in January 2015.
Sign-up for NeuroMetrix Selected to Showcase Quell™ Wearable Pain Relief Technology at 2015 CES Unveiled investment picks
NeuroMetrix, Inc. (Nasdaq: NURO) reported today that industry insiders got their first look at Quell during day 1 of this year’s International Consumer Electronics Show (CES). Quell utilizes NeuroMetrix’s proprietary non-invasive neurostimulation technology to provide relief from chronic pain, particularly nerve pain such as due to diabetes and lower back problems.
Sign-up for NeuroMetrix Launches Quell™ Wearable Pain Relief Technology at 2015 International Consumer Electronics Show to Strong Initial Interest investment picks
REHOVOT, Israel, Dec.
Sign-up for NeuroDerm CEO to Present at Oppenheimer Healthcare Conference on December 10, 2014 investment picks
World's Leading Internet Television Network to Offer Original Series, Movies, Documentaries, Stand-Up Comedy Specials and TV Shows for Low Monthly Price LOS GATOS, Calif.
Sign-up for Netflix To Launch In Australia And New Zealand In March 2015 investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, announced the presentation of the novel design of its Phase 3 Pyridorin PIONEER clinical program at the American Society of Nephrology (ASN) Kidney Week meeting held here November 11-16, 2014.
Sign-up for NephroGenex, Inc. Announces Presentation at the American Society of Nephrology’s Kidney Week 2014 investment picks
STOCKHOLM, Sweden, Dec.
Sign-up for Neonode to Demonstrate Cutting Edge Touch Technologies at CES 2015 investment picks
- GAAP net income $1.84 per share, $1.45 per share excluding adjustments - Servicing $130.8 billion student loans for 5.8 million borrowers under government contract - 32 percent increase in payment processing revenue driven by RenWeb acquisition LINCOLN, Neb.
Sign-up for Nelnet Reports Third Quarter 2014 Results investment picks
-- Findings Presented at 2014 San Antonio Breast Cancer Symposium (SABCS) -- SAN ANTONIO and SAN FRANCISCO , Dec.
Sign-up for Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3 BEACON Study of Etirinotecan Pegol (NKTR-102) in Patients with Advanced Breast Cancer investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153691&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for Navigator Holdings Ltd. Announces Date for the Release of Third Quarter 2014 Results, Conference Call and Webcast investment picks
Next year, the healthcare system will be front and center as the Supreme Court rules on the constitutionality of health insurance exchange subsidies and changes to the Affordable Care Act (ACA) continue.
Sign-up for Navigant Center for Healthcare Research and Policy Analysis Identifies Key Areas to Watch in 2015 investment picks
NEWARK, Del., Nov.
Sign-up for Navient to acquire $8.5 billion in federal student loans from Wells Fargo investment picks
Reports organic revenue growth of 5% for the third quarter Reports record Q3 non-GAAP EPS of $0.33 Increases annual revenue and non-GAAP earnings guidance PLEASANTON, Calif., Oct.
Sign-up for Natus Medical Announces Record Third Quarter and Year-to-Date 2014 Financial Results investment picks
Tucson Community Sustains Its "Appetite" for Natural Food Choices TUCSON, Ariz.
Sign-up for Natural Grocers Set to Open Store in Tucson on January 20 investment picks
ORLANDO, Fla.
Sign-up for National Retail Properties, Inc. Prices Offering Of Common Stock investment picks
Strongest year for listings at Nasdaq since 2000 with 189 IPOs NEW YORK, Dec.
Sign-up for Nasdaq Secures #1 Position for Total IPOs at U.S. Exchanges in 2014 investment picks
Jeff Gordon and Ray Evernham's 1999 No.24 Pepsi Chevrolet to Benefit Jeff Gordon Children's Foundation LAS VEGAS , Nov.
Sign-up for NASCAR Legends Jeff Gordon And Ray Evernham Restore Iconic Stock Car For Charity; Car To Be Featured At Barrett-Jackson Scottsdale On Velocity investment picks
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that multiple posters for the Prosigna ® Breast Cancer Gene Signature Assay based on PAM50 will be presented at the 37 th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). These include a prospective study of the Prosigna Assay on adjuvant clinical decision-making in women with Estrogen Receptor-Positive (ER+), HER2-negative, node-negative breast cancer.
Sign-up for NanoString Technologies Announces Prosigna Presentations at the 2014 CTRC-AACR San Antonio Breast Cancer Symposium investment picks
SALT LAKE CITY, Dec.
Sign-up for Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer Symposium investment picks
SALT LAKE CITY and ZURICH, Oct.
Sign-up for Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe investment picks
PITTSBURGH , Dec.
Sign-up for Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference investment picks
Submits Nominations for the Election of Four Highly Qualified Directors at Furmanite's 2015 Annual Meeting HOUSTON , Dec.
Sign-up for Mustang Capital Announces Proxy Contest at Furmanite Corporation investment picks
Incyte Corporation (Nasdaq: INCY) today announced that over 40 abstracts, detailing studies conducted by Incyte, Novartis and multiple independent investigators in patients with myeloproliferative neoplasms (MPNs), will be presented at the 50th Annual Meeting of the American Society of Hematology (ASH), which is to be held from December 6-9, 2014 in San Francisco.
Sign-up for Multiple Data Presentations at the 2014 American Society of Hematology (ASH) Annual Meeting Showcase Incyte's Leadership in the Field of Myeloproliferative Neoplasms (MPNs) investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: New Air Products Microsite Illustrates Novel Ways Liquid Nitrogen Can Improve Food Processing Operations to Multiple Data Presentations at the 2014 American Society of Hematology (ASH) Annual Meeting Showcase Incyte's Leadership in the Field of Myeloproliferative Neoplasms (MPNs)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent